Systemic sclerosis

Otylia Kowal-Bielecka; Anna Kuryliszyn-Moskal

eISSN: 2084-9834
ISSN: 0034-6233

Reumatologia/Rheumatology

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

2/2012
vol. 50

Send email

Copy url:

abstract:

Short communication

Systemic sclerosis

Otylia Kowal-Bielecka

,

Anna Kuryliszyn-Moskal

Reumatologia 2012; 50, 2: 124–129

Online publish date: 2012/06/01

View full text Get citation

Systemic sclerosis (scleroderma) is a chronic, connective tissue disease affecting skin, musculoscleletal system, cardiovascular system, the lungs, kidneys and gastrointestinal tract. Early detection and management of scleroderma-related organ involvement is of key importance for improving health-related quality of life and reduction of mortality in patients with systemic sclerosis. In view of significant heterogeneity in the clinical manifestations and progression of the disease, management of patient with systemic sclerosis should be designed based on the risk of and/or the presence of particular organ involvement (organ-specific therapy). Since there is only little evidence concerning efficacy of therapies used for treating scleroderma-related organ involvement, experience of a team providing treatment and clinical care has a pivotal role in proper management of patients with systemic sclerosis.

keywords:

systemic sclerosis, scleroderma, recommendations

EVENTS/KONFERENCJE

BOOKS/KSIĄŻKI

Systemic sclerosis

Otylia Kowal-Bielecka , Anna Kuryliszyn-Moskal

systemic sclerosis, scleroderma, recommendations

Otylia Kowal-Bielecka

,

Anna Kuryliszyn-Moskal